Return to Publications
May 2017
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.
Xiang-Lin Tan, MD, PhD

Examining the Impact of Diabetes and Cholesterol Drugs on Pancreatic Cancer Survival

Research has shown that by themselves the diabetes drug metformin and cholesterol-lowering statin drugs are associated with reduced cancer mortality, but little is known about the effect on pancreatic cancer mortality when these drugs are taken together. Rutgers Cancer Institute of New Jersey researcher Xiang-Lin Tan, MD, PhD, assistant professor of medicine at Rutgers Robert Wood Johnson Medical School and assistant professor of epidemiology at Rutgers School of Public Health, examined SEER Medicare data and found use of one of these drugs was significantly associated with improved survival.

Menendez Visit

Senator Menendez Visits Rutgers Cancer Institute

U.S. Senator Robert Menendez recently visited Rutgers Cancer Institute of New Jersey to learn about cancer treatment advances being made here in New Brunswick as well as to discuss the impact of proposed budget cuts to the National Institutes of Health on scientific research. As part of his tour, Senator Menendez visited our pharmacy to learn about clinical trials, as well as the laboratory of Rutgers Cancer Institute Deputy Director Chief Scientific Officer and Associate Director for Basic Science Eileen White, PhD to learn more about cancer cell metabolism and how that research is translated from the laboratory to the clinical setting.

East Tower

A New Location for our Hematologic Malignancies and Blood and Marrow Transplant Programs

Rutgers Cancer Institute of New Jersey's Hematologic Malignancies and Blood and Marrow Transplant Programs have a new location. Slated to open in the coming weeks, patients will have access to innovative patient care at a new campus location on the ninth floor of the Robert Wood Johnson University Hospital's East Tower Building, directly across the street from Rutgers Cancer Institute. Patients of these programs will be able to see their providers as well as receive their treatment regimens in this new state-of-the-art space. In addition, the new space will house the Rutgers Cancer Institute and RWJBarnabas Health's seven-day-a-week infusion area.

Jennifer Tsui, PhD

Bridging Health Equity in Our Communities

Highlighting awareness of a need to bridge health equity in communities has been part of a larger, nationwide conversation during National Minority Health Month. At focus in reducing the cancer burden in minority populations is ensuring individuals have access to high quality cancer screenings and treatments, adequate insurance coverage and other services. Jennifer Tsui, PhD, who is a resident research member in the Cancer Prevention and Control Program at Rutgers Cancer Institute of New Jersey, shares some insight on this topic.

Nurse Navigator

Rutgers Cancer Institute Nurses Present Findings on Benefits of Patient Navigators and Health Literacy at National Meeting

Navigating a treatment path for cancer can be challenging for many patients, especially coordination of appointments between multiple practitioners. Combine that with a wealth of information about the disease which may not be easy to understand and there exists the potential for poor health outcomes. Nurses at Rutgers Cancer Institute of New Jersey explored both topics in order to further enhance the patient experience. Their findings are being presented as part of a poster session at the Oncology Nursing Society's Annual Congress being held in early May.